Your browser doesn't support javascript.
loading
Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
Chu, Zhaoxing; Xu, Qinlong; Zhu, Qihua; Ma, Xiaodong; Mo, Jiajia; Lin, Gaofeng; Zhao, Yan; Gu, Yuanfeng; Bian, Lincui; Shao, Li; Guo, Jing; Ye, Wenfeng; Li, Jiaming; He, Guangwei; Xu, Yungen.
Afiliación
  • Chu Z; Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 211198, China; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Xu Q; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China; Department of Medicinal Chemistry, Anhui University of Chinese Medicine, Hefei, 230031, China.
  • Zhu Q; Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 211198, China; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China.
  • Ma X; Department of Medicinal Chemistry, Anhui University of Chinese Medicine, Hefei, 230031, China.
  • Mo J; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Lin G; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Zhao Y; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Gu Y; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Bian L; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Shao L; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Guo J; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Ye W; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China.
  • Li J; Department of Medicinal Chemistry, Anhui University of Chinese Medicine, Hefei, 230031, China.
  • He G; Hefei Institute of Pharmaceutical Industry Co., Ltd., Hefei, 230088, China. Electronic address: heguangwei@ahipi.com.
  • Xu Y; Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 211198, China; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China. Electronic address: xyg@cpu.edu.cn.
Eur J Med Chem ; 213: 113171, 2021 Mar 05.
Article en En | MEDLINE | ID: mdl-33482600
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Boro / Diseño de Fármacos / Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / Inhibidores de Fosfodiesterasa 4 Límite: Animals Idioma: En Revista: Eur J Med Chem Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Boro / Diseño de Fármacos / Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / Inhibidores de Fosfodiesterasa 4 Límite: Animals Idioma: En Revista: Eur J Med Chem Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Francia